WuXi AppTec reported revenue of RMB 45.54 billion for the first nine months of 2026, up 38.6% year over year; continuing-operations revenue increased 46.3%.
The company raised its 2026 revenue target to RMB 61.0–61.9 billion, from RMB 58.5–60.5 billion previously. It also lifted its continuing-operations growth outlook to 40–42%.
Profit attributable to owners rose to RMB 19.16 billion, and continuing-operations backlog reached RMB 76.74 billion, up 36.4%.
The results came despite U.S. regulatory and political uncertainty. WuXi was placed on the Defense Department’s Section 1260H list in June, but a U.S. court issued a preliminary injunction in August blocking enforcement of that designation while the case proceeds.
The company also raised its adjusted free-cash-flow forecast to RMB 14.5–15.5 billion and plans RMB 8.0–8.5 billion in 2026 capital spending.
Sources:
WuXi AppTec Delivers Strong Q1-Q3 2026 Results and Further ...
WuXi AppTec bucks DOD uncertainty through Q3, lifting forecast for 2026
WuXi AppTec raises full-year guidance after strong third ...
WuXi AppTec Raises 2026 Revenue Outlook to RMB 61.9 Billion as Nine-Month Profit Surges 74.4%
Press Releases & Company Updates
Integrated End-to-End CRDMO Platform
Chinese biotech giant WuXi AppTec raises 2026 outlook after profit surge
Life Science Company News, Pharma, Biotechnology, Medical ...
WuXi AppTec Raises 2026 Guidance as Nine-Month Revenue Rises 38.6% | TokenPost
WUXIF News Today | Why did WuXi AppTec stock go up today?
WuXi AppTec Raises 2026 Revenue Outlook to RMB 61....
WuXi AppTec Co., Ltd. Nine Months Income Advances